Company Filing History:
Years Active: 2007
Title: Eberhard Neumann: Innovator in Electroporation Technology
Introduction
Eberhard Neumann, based in Bielefeld, Germany, is an accomplished inventor known for his significant contribution to the field of electroporation technology. With one patent to his name, Neumann's work focuses on developing innovative solutions that enhance the introduction of substances into cells through the use of electric fields.
Latest Patents
Neumann's notable patent is an "Electroporation device and method, delivering a modulated signal under continuous control of cell electropermeabilization." This device features a signal generating circuit connected to electrodes placed on a substrate containing cells. The electrodes create an electric field that induces the permeabilization of cell membranes, facilitating the introduction of various substances into the cells. One of the unique aspects of this invention is that the amplitude of the signal applied to the electrodes is controlled in a closed-loop manner, based on the impedance of the substrate, allowing for precise regulation in response to changes resulting from membrane permeabilization.
Career Highlights
Eberhard Neumann works at Igea S.r.l., where he has made strides in advancing electroporation technology. His commitment to innovation is evident through his patent, which reflects years of research and development aimed at optimizing cellular processes for various applications, including drug delivery and biotechnological advancements.
Collaborations
Throughout his career, Neumann has collaborated with esteemed colleagues, including Damijan Miklavcic and Lluis Mir. These collaborations have played a crucial role in refining his inventions and expanding the reach of his electroporation technology within the scientific community.
Conclusion
Eberhard Neumann's dedication to research and innovation in the field of electroporation has resulted in impactful advancements that enhance cellular permeability for various applications. His patent reflects a strong commitment to improving biotechnological methods, which could lead to significant developments in medicine and biotechnology in the future.